For the usage as blood substitutes perfluorocarbons (PFC) have been develop
ed as artificial oxygen carriers. In addition they may have potency for pro
tective use in ischemic tissue. Formulation improvement achieved higher oxy
gen carrying capacity and better compatibility than the first generation of
PFC. Preclinical studies have been performed in animal heart and brain. Fo
rmer and progressed emulsification for intravascular use have been investig
ated for infarction and reperfusion injury. This investigations are reviewe
d and the potencies for the use of PFC in neurology, neurosurgery, diagnost
ics today and in the future are emphasized.